Business
Biotech Analysts See Drastic Change For Industry Earnings
Biotechs have emerged as an interesting option for investors. The State Street SPDR S&P Biotech ETF (XBI) broke out above a buy point last week and remains in that price area. The biotech fund is one of two ETFs in IBD Leaderboard. The S&P 500 Biotech index gapped up to nearly an all-time high last Wednesday, a bullish day for…
Copyright ©2026 Investor’s Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8
You must be logged in to post a comment Login